Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.5 (
RNase
)
17,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein tyrosine phosphatases are involved in the regulation of important cellular processes such as signal transduction, cell cycle progression, and tumor suppression. Here we report the cloning and characterization of
PIR1
, a novel member in the dual-specificity phosphatase subfamily of the protein tyrosine phosphatases.
PIR1
also contains two stretches of arginine-rich sequences. We have shown that the recombinant
PIR1
protein possessed an intrinsic phosphatase activity on phosphotyrosine-containing substrate. A unique feature of this phosphatase is that it binds directly to RNA in vitro with high affinity. In addition, we have found that
PIR1
interacted with splicing factors 9G8 and SRp30C, possibly through an RNA intermediate during a yeast two-hybrid screen.
PIR1
exhibited a nuclear-staining pattern that was sensitive to
RNase A
, but not to DNase I, suggesting that
PIR1
in the cells are associated with RNA and/or ribonucleoprotein particles. Furthermore, a fraction of
PIR1
showed a speckle-staining pattern that superimposed with that of the splicing factor, SC35. Taken together, our data suggest that
PIR1
is a novel phosphatase that may participate in nuclear mRNA metabolism.
...
PMID:PIR1, a novel phosphatase that exhibits high affinity to RNA . ribonucleoprotein complexes. 968 86